Ellis Investment Partners, LLC - GW PHARMACEUTICALS PLC ownership

Back to all holdings Add to watchlist

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Ellis Investment Partners, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$5,000
+66.7%
250.0%0.00%0.0%
Q4 2020$3,000
+50.0%
250.0%0.00%0.0%
Q3 2020$2,000
-33.3%
250.0%0.00%0.0%
Q2 2020$3,000
+50.0%
250.0%0.00%0.0%
Q1 2020$2,0000.0%250.0%0.00%0.0%
Q4 2019$2,000–25–0.00%–
 Download
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders